Thoracic Tumors clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol)
open to eligible people ages 18-100
The study aims to determine maximum tolerated dose (MTD) or recommended combination dose of the MTA-cooperative PRMT5 inhibitor AMG 193 administered in combination with other therapies in adult participants with metastatic or locally advanced…
Orange, California and other locations
Last updated: